Scott Seaman

Scott Seaman is a Senior Medical Strategy Manager at United Therapeutics Corporation, a position held since September 2021. Prior to this role, Scott served as a Senior Product Development Scientist and Product Development Engineer at Bioventus from November 2016 to September 2021. Academic experience includes a Postdoctoral Research Associate role at the University of Virginia from August 2010 to November 2016, where Scott designed pre-clinical studies in collaboration with AstraZeneca and developed an oxygen-sensing wound diagnostic device. Scott earned a Ph.D. in Biomedical Engineering from the University of Virginia, with research focused on enhancing autologous fat grafting survival rates through improved vascularization. Additional experience includes a research internship at LifeNet Health and technical support for hematology analyzers. Scott holds a Bachelor of Science in Biomedical Engineering from Georgia Institute of Technology.